Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation

被引:13
|
作者
Hjerpe, Roland [1 ]
Aillet, Fabienne [1 ]
Lopitz-Otsoa, Fernando [1 ]
Lang, Valerie [1 ]
Torres-Ramos, Monica [1 ]
Farras, Rosa [3 ]
Hay, Ronald T. [4 ]
Rodriguez, Manuel S. [1 ,2 ]
机构
[1] CIC bioGUNE, Prote Unit, CIBERehd, Derio 48160, Bizkaia, Spain
[2] Univ Basque Country, Dept Biochem, Leioa 48940, Bizkaia, Spain
[3] Ctr Invest Principe Felipe, Valencia 46013, Spain
[4] Univ Dundee, Sch Life Sci, Interdisciplinary Res Ctr, Dundee DD1 5EH, Scotland
关键词
p53; Polyubiquitylation; Degradation; Mdm2; Proteasome; TERMINAL DOMAIN; TRANSCRIPTIONAL ACTIVITY; PROTEIN-DEGRADATION; ACTIVATE P53; IN-VIVO; UBIQUITINATION; MDM2; MULTIPLE; IDENTIFICATION; MUTATIONS;
D O I
10.1016/j.biocel.2010.01.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In normal cells p53 is maintained at low level through the action of the ubiquitin-proteasome system. As a consequence of p53 transcriptional activity, various regulators of this tumor suppressor are produced, forming a negative feedback loop tightly controlling p53 stability. One of the most prominent is the ubiquitin-ligase Mdm2. Here, we have used a transfer of signals strategy to study the p53 degradation process promoted by Mdm2 in the absence of p53 transcriptional activity. Our results show that in a p53 null background, transcriptionally silent p53-fusions require multiple N- and C-terminal signals to be optimally targeted to proteasomal degradation. As for WT p53, p53-fusions able to form tetramers are polyubiquitylated and optimally degraded by the proteasome. However, p53 molecules unable to oligomerize, show Mdm2-mediated polyubiquitylation deficiency but are still targeted to proteasome degradation in vitro and ex vivo. In the presence of Mdm2, nuclear shuttling of p53 monomeric fusions favours proteasome-dependent degradability but not its polyubiquitylation. In vitro, 265 proteasome fails to drive degradation of OD mutants in the presence of Mdm2, suggesting the contribution of additional cellular factors in this process. All together, our results indicate that Mdm2-mediated proteasome-dependent degradation of polyubiquitylation deficient p53 monomers is mechanistically possible, taking alternative pathways to better achieve their proteolysis. These results support the existence of additional levels to regulate p53 stability and activity acting on individual subunits of the functional tetramer. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:725 / 735
页数:11
相关论文
共 50 条
  • [41] Anoikis triggers Mdm2-dependent p53 degradation
    Abhijit Ghosh
    Tina Chunyuan Chen
    Yvonne L. Kapila
    Molecular and Cellular Biochemistry, 2010, 343 : 201 - 209
  • [42] Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    Chen, D.
    Zhang, Z.
    Li, M.
    Wang, W.
    Li, Y.
    Rayburn, E. R.
    Hill, D. L.
    Wang, H.
    Zhang, R.
    ONCOGENE, 2007, 26 (35) : 5029 - 5037
  • [43] BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation
    Prabhu Thirusangu
    V. Vigneshwaran
    T. Prashanth
    B. R. Vijay Avin
    Vikas H. Malojirao
    H. Rakesh
    Shaukath Ara Khanum
    Riaz Mahmood
    B. T. Prabhakar
    Angiogenesis, 2017, 20 : 55 - 71
  • [44] MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53
    Wang, Yu-Sheng
    Yin, Ji-Zhong
    Shi, Xiao-Qian
    Zhao, Xue-Wei
    Li, Bing
    Yang, Meng-Hang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (16) : 1829 - 1837
  • [45] BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation
    Thirusangu, Prabhu
    Vigneshwaran, V.
    Prashanth, T.
    Avin, B. R. Vijay
    Malojirao, Vikas H.
    Rakesh, H.
    Khanum, Shaukath Ara
    Mahmood, Riaz
    Prabhakar, B. T.
    ANGIOGENESIS, 2017, 20 (01) : 55 - 71
  • [46] The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation
    Nishida, Tamotsu
    Yamada, Yoshiji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 406 (02) : 285 - 291
  • [47] The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a
    A Sparks
    S Dayal
    J Das
    P Robertson
    S Menendez
    M K Saville
    Oncogene, 2014, 33 : 4685 - 4696
  • [48] Hydrogen sulfide inhibits alveolar type II cell senescence and limits pulmonary fibrosis via promoting MDM2-mediated p53 degradation
    Wang, Xiu-Li
    Xu, Yi-Tong
    Zhang, Shu-Li
    Zhu, Xiao-Yan
    Zhang, Hong-Xia
    Liu, Yu-Jian
    ACTA PHYSIOLOGICA, 2024, 240 (01)
  • [49] CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination
    Latini, Paolo
    Frontini, Mattia
    Caputo, Manuela
    Gregan, Juraj
    Cipak, Lubos
    Filippi, Silvia
    Kumar, Vivek
    Velez-Cruz, Renier
    Stefanini, Miria
    Palitti, Fabrizio
    Proietti-De-Santis, Luca
    CELL CYCLE, 2011, 10 (21) : 3719 - 3730
  • [50] Inhibition of p53 degradation by Mdm2 acetylation
    Wang, XJ
    Taplick, J
    Geva, N
    Oren, M
    FEBS LETTERS, 2004, 561 (1-3): : 195 - 201